Indian Dermatology Online Journal

REVIEW ARTICLE
Year
: 2020  |  Volume : 11  |  Issue : 4  |  Page : 482--492

What is new in the pathogenesis and management of erythema nodosum leprosum


Ramesh M Bhat, Tanvi P Vaidya 
 Department of Dermatology, Father Muller Medical College, Mangalore, Karnataka, India

Correspondence Address:
Ramesh M Bhat
Department of Dermatology, Father Muller Medical College, Kankanady, Mangalore - 575 002, Karnataka
India

Erythema nodosum leprosum (ENL) is a manifestation of type II lepra reaction, seen in lepromatous or borderline lepromatous leprosy. Although it is a common reaction encountered in clinical practice, there are an increasingly large number of newer updates in the pathophysiology and management of this condition.The treatment options have expanded far beyond just thalidomide and steroids and now extends to TNF-α inhibitors, thalidomide analogs, tenidap, cyclosporine A, plasma exchange, and even IVIG amongst others. These updates and the current knowledge of ENL are summarized in this review.


How to cite this article:
Bhat RM, Vaidya TP. What is new in the pathogenesis and management of erythema nodosum leprosum.Indian Dermatol Online J 2020;11:482-492


How to cite this URL:
Bhat RM, Vaidya TP. What is new in the pathogenesis and management of erythema nodosum leprosum. Indian Dermatol Online J [serial online] 2020 [cited 2020 Aug 3 ];11:482-492
Available from: http://www.idoj.in/article.asp?issn=2229-5178;year=2020;volume=11;issue=4;spage=482;epage=492;aulast=Bhat;type=0